Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ELOX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 61.97M
March 31, 2026 6.369M
June 30, 2025
September 30, 2023 4.994M
June 30, 2023 4.541M
March 31, 2023 5.165M
December 31, 2022 19.47M
September 30, 2022 24.82M
June 30, 2022 30.31M
March 31, 2022 40.06M
December 31, 2021 42.57M
September 30, 2021 52.68M
June 30, 2021 56.98M
March 31, 2021 18.30M
December 31, 2020 24.72M
September 30, 2020 30.64M
June 30, 2020 37.17M
March 31, 2020 44.00M
December 31, 2019 56.32M
September 30, 2019 64.98M
June 30, 2019 76.34M
March 31, 2019 53.55M
December 31, 2018 48.65M
September 30, 2018 55.38M
June 30, 2018 63.51M
Date Value
March 31, 2018 18.40M
June 30, 2017 0.0332M
March 31, 2017 0.242M
December 31, 2016 0.1492M
September 30, 2016 0.2871M
June 30, 2016 0.8108M
March 31, 2016 1.526M
December 31, 2015 2.367M
September 30, 2015 3.355M
June 30, 2015 3.335M
March 31, 2015 0.47M
December 31, 2014 2.108M
September 30, 2014 3.837M
June 30, 2014 6.111M
March 31, 2014 6.198M
December 31, 2013 6.122M
September 30, 2013 0.7892M
June 30, 2013 1.602M
March 31, 2013 1.581M
December 31, 2012 0.6401M
September 30, 2012 1.312M
June 30, 2012 2.001M
March 31, 2012 3.207M
December 31, 2011 1.553M
September 30, 2011 2.842M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 82.68M
CorMedix, Inc. 257.35M
Cannabis Global, Inc. 0.0116M
Breakthrough Chemistry, Inc. 1.215M
BioStem Technologies, Inc. 6.962M